So... Richard just said above (back in 2019) that the MPL target market that PAA/Elanco aim to achieve (for B-cell Lymphoma cancer in canines) is roughly between
$1B and $4BILLION DOLLARS...
I know this may have been previously calculated in these threads, but it needs to be mentioned again...
I guess a 10% cut is pretty easy to work out
But who knows how big this deal could end up...
We can only adreamer...
So... Richard just said above (back in 2019) that the MPL target...
-
- There are more pages in this discussion • 306 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.1M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 22.5¢ | $9.238K | 41.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 78996 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 124981 | 4 |
View Market Depth
| Last trade - 10.06am 17/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |